Adelaide Research & Scholarship: Search

Search

Results 1-10 of 11 (Search time: 0.003 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2001	Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase	Litjens, T.; Hopwood, J.
	2007	Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI	Auclair, D.; Hopwood, J.; Lemontt, J.; Chen, L.; Byers, S.
	2003	Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy	Auclair, D.; Hopwood, J.; Brooks, D.; Lemontt, J.; Crawley, A.
	2012	Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats	Auclair, D.; Finnie, J.; Walkley, S.; White, J.; Nielsen, T.; Fuller, M.; Cheng, A.; O'Neill, C.; Hopwood, J.
	1996	Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome	Crawley, A.; Brooks, D.; Muller, V.; Petersen, B.; Isaac, E.; Bielicki, J.; King, B.; Boulter, C.; Moore, A.; Fazzalari, N.; Anson, D.; Byers, S.; Hopwood, J.
	1997	Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI	Crawley, A.; Niedzielski, K.; Isaac, E.; Davey, R.; Byers, S.; Hopwood, J.
	1998	Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes	Crawley, A.; Yogalingam, G.; Muller, V.; Hopwood, J.
	2000	Enzyme replacement therapy in a feline model of MPS VI: Modification of enzyme structure and dose frequency	Byers, S.; Crawley, A.; Brumfield, L.; Nuttall, J.; Hopwood, J.
	1999	Evaluation of fibroblast-mediated gene therapy in a feline model of mucopolysaccharidosis type VI	Yogalingam, G.; Crawley, A.; Hopwood, J.; Anson, D.
	1998	Immune response to enzyme replacement therapy: clinical signs of hypersensitivity reactions and altered enzyme distribution in a high titre rat model	Brooks, D.; Hopwood, J.; King, B.